Thursday, February 12, 2026
ADVT 
National

Health officials investigating kids' liver disease

Darpan News Desk The Canadian Press, 27 Apr, 2022 09:57 AM
  • Health officials investigating kids' liver disease

OTTAWA - The Public Health Agency of Canada says it looking into reports of severe acute hepatitis, or liver inflammation, among young children in Canada.

The federal agency says the cases are being investigated to determine if they are related to those in the United Kingdom and the United States.

A spokesperson did not share any further details, such as the number of cases, age of the children or their health condition.

British health officials have said they are investigating what's behind a spike there, noting there is increasing evidence the cases could be linked to a common virus.

The U.K. Health Security Agency said earlier it has recorded 111 cases of unexplained hepatitis in children under 10 since January. Ten of the children needed liver transplants. The U.N. health agency said it has so far received reports of at least 169 cases of "acute hepatitis of unknown origin," and that one death had been reported.

While it isn't clear what's causing the illnesses, a leading suspect is adenovirus, which was detected in 75 per cent of the confirmed cases tested, the U.K. agency said in statement Monday.

Adenovirus, a common group of viruses, is now circulating in children at higher than average levels after dropping to unusually low levels during the pandemic.

One avenue of inquiry being explored is that the outbreak may be linked to a surge in common viral infections after COVID-19 restrictions were phased out. Children who weren't exposed to adenovirus over the last two years may now be getting hit harder when they are exposed to the viruses.

There are dozens of adenoviruses, many associated with cold-like symptoms, fever, sore throat and pink eye.

U.S. authorities said earlier this month that they were investigating a cluster of otherwise unexplained hepatitis cases diagnosed in nine Alabama children who also tested positive for adenovirus.

MORE National ARTICLES

Emergency powers end but questions linger

Emergency powers end but questions linger
Prime Minister Justin Trudeau announced Wednesday the extraordinary, time-limited powers would be pulled back now that the immediate crisis is over. They were brought in last week to respond to protests and blockades against COVID-19 restrictions and the Liberal government.

Emergency powers end but questions linger

Attempted robbery in Richmond involves snatching of a senior's purse

Attempted robbery in Richmond involves snatching of a senior's purse
One of the occupants of the SUV tried pulling her inside the vehicle and stealing her purse. The suspect or suspects then fled in this vehicle after their attempt was unsuccessful.

Attempted robbery in Richmond involves snatching of a senior's purse

A look at the Omicron subvariant BA.2

A look at the Omicron subvariant BA.2
BA.2 was detected in Canada as early as December, according to Health Canada data, but a report last week from the B.C. COVID-19 modelling group suggests the newer Omicron strain could be spreading faster in parts of the country than the current dominant version, BA.1.

A look at the Omicron subvariant BA.2

Alberta budget set to rebound on high oil prices

Alberta budget set to rebound on high oil prices
 It's budget day in Alberta, and Premier Jason Kenney says there will be a massive infusion of money for the health-care system. Kenney says the COVID-19 pandemic has exposed a system that has too few hospital beds, labs and intensive care spaces.

Alberta budget set to rebound on high oil prices

Trudeau condemns Russia's attack on Ukraine

Trudeau condemns Russia's attack on Ukraine
Trudeau said he would be meeting Thursday with G7 partners and would work quickly with NATO and Canada's allies "to collectively respond to these reckless and dangerous acts, including by imposing significant sanctions in addition to those already announced."

Trudeau condemns Russia's attack on Ukraine

Ottawa approves made-in-Canada COVID vaccine

Ottawa approves made-in-Canada COVID vaccine
Health Canada says its effectiveness and safety in those under 18 and over 64 have "not yet been established." Clinical trials suggested the vaccine was 71 per cent effective in protecting against COVID-19 one week after the second dose. The dosing schedule is 21 days apart.

Ottawa approves made-in-Canada COVID vaccine